WEHI will use the information you have provided to register you for the event, manage your attendance, and contact you about future events. Personal information collected is in accordance with WEHI’s Privacy Policy. We will not disclose your information to any other third party unless doing so is authorised or required by law, or we have your consent to do so. You have the right to access, or seek correction of, the personal information we hold about you, or to make a privacy complaint.
For more information, please see our Privacy Policy or contact WEHI’s Privacy Officer at privacy@wehi.edu.au.
Andrew is a clinical haematologist who cares for patients at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre. He is also a Deputy Director of WEHI, leading translational research focused on developing new treatments for blood cancers, especially those that are currently incurable.
Peter is a medical oncologist leading a team of oncologists who manage national and international cancer registries and undertake registry-based and international randomised trials. Peter and his team are studying how organoids – models grown in the lab from a patient’s own tumour – can be used to improve treatment outcomes for colorectal cancer.
Misty is a renowned immunologist whose team currently focuses on designing and testing a type of adaptive T cell immunotherapy called CAR T cells as a new treatment for adult and paediatric brain tumours. Their ultimate goal is to improve the prognosis for patients with low-survival brain cancers.
Clare is a clinician scientist, leading the Ovarian and Rare Gynaecological Cancers Laboratory at WEHI and working as a medical oncologist at the Peter MacCallum Cancer Centre, Royal Women’s and Royal Melbourne Hospitals. Her laboratory focuses on developing targeted treatment strategies for ovarian cancer and other rare cancers.